Pulmonx Corp financial data

Symbol
LUNG on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
700 Chesapeake Drive, Redwood City, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
PULMONX (to 2/7/2012)
Latest financial report
10-K - Q4 2024 - Feb 25, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 711 % -11.3%
Quick Ratio 84.8 % +6.1%
Debt-to-equity 70.5 % +56.5%
Return On Equity -57.6 % -23.6%
Return On Assets -33.8 % -5.13%
Operating Margin -68.9 % +23.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 39.8M shares
Common Stock, Shares, Outstanding 39.8M shares +3.3%
Common Stock, Value, Issued 40K USD +2.56%
Weighted Average Number of Shares Outstanding, Basic 39.1M shares +2.99%
Weighted Average Number of Shares Outstanding, Diluted 39.1M shares +2.99%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 83.8M USD +22%
Research and Development Expense 17.6M USD -2.82%
Operating Income (Loss) -57.7M USD +6.83%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -55.9M USD +7.26%
Income Tax Expense (Benefit) 500K USD -12.4%
Net Income (Loss) Attributable to Parent -56.4M USD +7.31%
Earnings Per Share, Basic -1.44 USD/shares +10%
Earnings Per Share, Diluted -1.44 USD/shares +10%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 70.9M USD -15.1%
Accounts Receivable, after Allowance for Credit Loss, Current 13.1M USD +8.39%
Inventory, Net 16.9M USD +1.03%
Other Assets, Current 1.13M USD +124%
Assets, Current 136M USD -9.42%
Property, Plant and Equipment, Net 2.91M USD -27.8%
Operating Lease, Right-of-Use Asset 18.5M USD +444%
Goodwill 2.33M USD 0%
Other Assets, Noncurrent 1.14M USD +92.2%
Assets 163M USD -8.4%
Accounts Payable, Current 3.83M USD +156%
Accrued Liabilities, Current 16.5M USD +1.47%
Contract with Customer, Liability, Current 135K USD +29.8%
Liabilities, Current 24.4M USD +5.53%
Deferred Income Tax Liabilities, Net 87K USD -23.7%
Operating Lease, Liability, Noncurrent 18.5M USD +1574%
Liabilities 77M USD +29.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2.11M USD -20%
Retained Earnings (Accumulated Deficit) -468M USD -13.7%
Stockholders' Equity Attributable to Parent 85.8M USD -27.5%
Liabilities and Equity 163M USD -8.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 39.8M shares +3.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 71.2M USD -15.1%
Deferred Tax Assets, Valuation Allowance 90.6M USD +14.2%
Deferred Tax Assets, Gross 95.5M USD +18.5%
Operating Lease, Liability 19.3M USD +362%
Depreciation 1.1M USD -21.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -56.9M USD +4.78%
Lessee, Operating Lease, Liability, to be Paid 31.3M USD +620%
Property, Plant and Equipment, Gross 8.63M USD -2.84%
Operating Lease, Liability, Current 778K USD -74.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.67M USD +143%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.57M USD -20.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +44.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12M USD +7084%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.7M USD +8893%
Deferred Tax Assets, Operating Loss Carryforwards 65.5M USD +14.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 8.87M USD +2.42%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.73M USD
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 100K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 4.86M USD +315%
Share-based Payment Arrangement, Expense 23M USD +3.86%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%